MetaCap

ClearPoint Neuro (CLPT) vs Mobia Medical (MOBI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

ClearPoint Neuro is the larger company by market cap ($320.0 million vs $285.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CLPT-16.85%MOBI-27.57%
+56%+12%-32%
May 8, 20261 yearOct 7, 2026
CLPT-16.85%MOBI-27.57%
+50%+9%-31%
May 4, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CLPT versus MOBI key metrics
MetricCLPTMOBI
Share price$10.49$8.56
Market cap$319.99M$284.97M
1-day change-1.59%+0.59%
YTD return-22.08%—
1-year return-59.61%—
5-year return-40.65%—
EPS (TTM)$-1.18$-2.96
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$30.10$15.29
52-week low$8.27$8.30
Distance from 52-week high-65.15%-44.02%
Analyst consensusstrong_buynone
Avg. price target upside+124.02%+107.36%
Average volume637.17K180.23K
Shares outstanding30.50M33.29M
Employees160167
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ClearPoint Neuro

CLPT stock →

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.

Health Care · Medical/Dental Instruments · 160 employees

About Mobia Medical

MOBI stock →

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.

Health Care · Medical/Dental Instruments · 167 employees

CLPT vs MOBI FAQ

Which is bigger, ClearPoint Neuro or Mobia Medical?

ClearPoint Neuro (CLPT) is larger, with a market capitalization of $319.99M compared with $284.97M for Mobia Medical (MOBI).

Are ClearPoint Neuro and Mobia Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons